7. panická porucha

More documents

Recommendations

Info

Lepola, U., Wade, A.G., Leihonen, E.V. et al. A controlled one year trial with citalopram in the treatment of panic disorder. J. Clin. Psychiatry 1998: 59: 528-534 Lesser, I.M., Rubin, R.T., Pecknold, J.C. et al. Secondary depression in panic disorder and agoraphobia. Arch. Gen. Psychiatry. 1988, 45: 437-443 Liebowitz, M.R., Fyer, A.J. McGrath, P. et al. Clonidine treatment of panic disorder. Psychopharmacol. Bull. 1981; 17: 122-123Lipsedge et al. 1973 Louie, A.K., Lewis, T.B., Lannon, R.A.: Use of low-dose fluoxetine in major depression and panic disorder. J. Clin. Psychiatry. 1993: 54: 435-438 Lum, M., Fontaine, R., Elie, R. et al. Probable interaction of sodium divalproate with benzodiazepines. Prog. Neuropsychopharmacol. Biol. Psychiatry 1991; 15: 269-273 Lydiard, R.B.: Desipramine in agoraphobia with panic attacks: an open, fixed - dose study. J. Clin. Psychopharmacol. 1987:7: 258-260 Lyiard RB. Comorbidity of panic disorder, phobia and major depression. European Psychiatry 1995; 10 (Suppl. 2): 65S-66S Manassis, K., Bradley, S., Goldberg, S. et al. Attachment in mothers with anxiety disorders and their children. J. Am. Acad. Child. Adolesc. Psychiatry. 1994: 33: 1106- 1113 Marchesi, C., Ampollini, P., Signifredi, R., Maggini, C.: The treatment of panic disorder in a clinical setting: a 12-month naturalistic study. Neuropsychobiology 1997; 36: 25-31 Margraf, J., Schneider, S.: Oucome and active ingredients of congnitive-behavioral treatments for panic disorder. Presented at the 25th annual meeting of the Association for Advancement of Behavior Therapy: November 1991: New York, NY. Margraf, G., Barlow, D.H., Clark, D.M., a Telch, M.J.: Psychological treatment of panic: work in progress in outcome, active ingredients, and follow – up. Behaviour Research and Therapy 1993; 31: 1-8. Marriott P, Judd F, Jefferys D et al. Panic and phobic disorders: Part I: Problems associated with drug therapy. Curr Ther 1989; 107-121. Matuzas, W. a Jack, E.: The drug treatment of panic disorder. Psychiatr. Med. 1991: 9: 215-243 Marks, I.M.: Fear and phobias. Heineman. London: 1969 Marks, I.M., Swinson, R.P., Basoglu, M. et al. Alprazolam and exposure alone and combined in panic disorder with agoraphobia. Br. J. Psychiatry 1993; 162: 776-787 Mavissakalian, M.: Imipramine treatment of panic disorder with agoraphobia: the second time around. J. Psychiatr. Res. 1993: 27: 61-68 Mavissakalian, M.: Sequential combination of imipramine and behavioral instructions in the treatment of panic disorder with agoraphobia. Arch. Gen. Psychiatry 1990: 46: 127-131 Mavissakalian, M., Barlow, D.H.: Phobia: psychological and pharmacological treatment. New York: Guilford Press, 1981 42
Mavissakalian, M., Perel, J.M.: Protective effects of imipramine maintenance treatment in panic disorder with agoraphobia. Am. J. Psychiatry. 1992: 149: 1053- 1057 Mc Tavish D, Benfield P. Clomipramine. An overview of its pharmacological properties and a review of its therapeutic use in obsessive compulsive disorder and panic disorder. Drugs 1990; 39: 136-153 Meco, G., Capriani, C., Bonifati, V. et al. Etizolam: a new therapeutic possibility in the treatment of panic disorder. Adv. Ther. 1989: 6: 196-206. Mezinárodní klasifikace nemocí. 10.revize. Duševní poruchy a poruchy chování: Diagnostická kritéria pro výzkum. (přeloženo z anglického originálu) Praha, Psychiatrické centrum 1996, Zprávy č. 134, 179s. Milrod, B. a Shear, M.K.: Dynamic treatment of panic disorder: a review. J.Nerv. Ment. Dis. 1991; 179: 741-743. Milrod, B., Bush, F. Cooper, A, Shapiro, T.: Manual of panic-focused psychodynamic psychotherapy. Washington, DC, American Psychiatric Press, 199<strong>7.</strong> Milrod B, Busch F, Leon AC et al. Open trial of psychodynamic psychotherapy for panic disorder: A pilot study. Am J Psychiatry 2000; 157: 1878-1880. Modigh, K. Westberg, P. a Eriksson, E.: Superiority of clomipramine over imipramine in the treatment of panic disorder: a placebo-controlled trial. J. Clin. Psychopharmacol. 1992: 12: 251-261 Možný, P., Praško, J.: Kognitivně-behaviorální terapie: úvod do teorie a praxe. Triton, Praha 1999, 304s Munjack, D.J, Crocker, B., Cabe, D. et al. Alprazolam, propranolol and placebo in the treatment of panic disorder and agoraphobia with panic attacks. J. Clin. Psychopharmacol. 1989; 9: 22-2<strong>7.</strong> Munjack, D.J., Usigli, R., Zulueta, A. et al. Nortriptyline in the treatment of panic disorder and agoraphobia with panic attacks. J. Clin. Psychopharmacol. 1988: 8: 204- 207 Nemiah, J.C.: The psychodynamic view of anxiety: an historical perspective. In: Roth,M., Noyes, R., Burrows, G.D. (eds.): Handbook of Anxiety, vol 1. New York, NY: Elsevier Science: 1988: 277-305 Newman, C.F., Beck, J.S., Beck, A.T.:Efficacy of cognitive therapy in reducing panic attacks and medication. Presented at the 24th annual meeting of the Association for Advancement of Behavior Therapy: November 1990: San Francisco, Calif Noyes, R., Anderson, D. J., Clancy, M.: Diazepam and Propranolol in Panic Disorder and Agoraphobia. Arch. Gen. Psychiatry 1984: 41: s.287-292 Noyes, R., Crowe, R.R., Harris, E.L.: Relationship between panic disorder and agoraphobia. Arch. Gen. Psychiatry 1986; 43: 227-232 Noyes. R., DuPont, R.L., Pecknold, J.C. et al. Alprazolam in panic disorder and agoraphobia: results from a multicenter trial, II: patient acceptance, side effects, and safety. Arch. Gen. Psychiatry. 1988: 45: 423-428 43
Page 1 and 2: 7. PANICKÁ PORUCHA Ján Praško, R
Page 3 and 4: Obrázek 7.1.: Kognitivní model pa
Page 5 and 6: Příznaky týkající se duševní
Page 7 and 8: z panického záchvatu. Vyhýbání
Page 9 and 10: Dlouhodobé epidemiologické studie
Page 11 and 12: Léčbu můžeme rozdělit na krát
Page 13 and 14: Sheehan et al. 1984 Dunner et al. 1
Page 15 and 16: tolerována a řada pacientů je pr
Page 17 and 18: SSRI jsou dnes pokládány za léky
Page 19 and 20: 1998 PLA Barlow et al. 1998 Pollack
Page 21 and 22: Dlouhodobá léčba Ukazuje se, že
Page 23 and 24: Významně účinnější byla lé
Page 25 and 26: 1994 AR IMI WL Wiborg a Dahl 1996 D
Page 27 and 28: stanovení diagnózy rozhodnutí o
Page 29 and 30: začne nacvičovat zvládání těl
Page 31 and 32: málo účinné, druhé účinné b
Page 33 and 34: Obrázek 7.4.: Postup v léčbě pa
Page 35 and 36: Literatura Alexander PE: Management
Page 37 and 38: Baumel, B., Bielski, R., Carman, J.
Page 39 and 40: Faravelli, C., Paterniti, S. a Scar
Page 41: Kasper S. Pharmakoterapie der Angst
Page 45 and 46: Praško, J., Pašková, B, Praškov
Page 47: Tondo, L., Burrai, C., Scamonatti,

7. panická porucha

Create successful ePaper yourself

Delete template?

Save as template?